Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
- Published In:
- The Journal of clinical endocrinology and metabolism, 99(12), E2463-71 (2014)
- Authors:
- Mear, Yves, Blanchard, Marie-Pierre, Defilles, Céline, Brue, Thierry, Figarella-Branger, Dominique, Graillon, Thomas, Manavela, Marcos, Barlier, Anne, Enjalbert, Alain, Thirion, Sylvie
- Database ID:
- RPEP-02442
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02442APA
Mear, Yves; Blanchard, Marie-Pierre; Defilles, Céline; Brue, Thierry; Figarella-Branger, Dominique; Graillon, Thomas; Manavela, Marcos; Barlier, Anne; Enjalbert, Alain; Thirion, Sylvie. (2014). Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.. The Journal of clinical endocrinology and metabolism, 99(12), E2463-71. https://doi.org/10.1210/jc.2014-2753
MLA
Mear, Yves, et al. "Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.." The Journal of clinical endocrinology and metabolism, 2014. https://doi.org/10.1210/jc.2014-2753
RethinkPeptides
RethinkPeptides Research Database. "Ghrelin receptor (GHS-R1a) and its constitutive activity in ..." RPEP-02442. Retrieved from https://rethinkpeptides.com/research/mear-2014-ghrelin-receptor-ghsr1a-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.